Cite
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis.
MLA
Caussy, Cyrielle, et al. “Plasma Eicosanoids as Noninvasive Biomarkers of Liver Fibrosis in Patients with Nonalcoholic Steatohepatitis.” Therapeutic Advances in Gastroenterology, vol. 13, Jan. 2020, pp. 1–13. EBSCOhost, https://doi.org/10.1177/1756284820923904.
APA
Caussy, C., Chuang, J.-C., Billin, A., Hu, T., Wang, Y., Subramanian, G. M., Djedjos, C. S., Myers, R. P., Dennis, E. A., & Loomba, R. (2020). Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology, 13, 1–13. https://doi.org/10.1177/1756284820923904
Chicago
Caussy, Cyrielle, Jen-Chieh Chuang, Andrew Billin, Tao Hu, Ya Wang, G. Mani Subramanian, C. Stephen Djedjos, Robert P. Myers, Edward A. Dennis, and Rohit Loomba. 2020. “Plasma Eicosanoids as Noninvasive Biomarkers of Liver Fibrosis in Patients with Nonalcoholic Steatohepatitis.” Therapeutic Advances in Gastroenterology 13 (January): 1–13. doi:10.1177/1756284820923904.